Vical researches and develops biopharmaceutical products based on our patented DNA delivery and vaccine technologies for the prevention and treatment of serious or life-threatening diseases.
Our active independent and partnered development programs include:
- Infectious disease vaccines for use in high-risk populations
- Infectious disease vaccines for general pediatric, adolescent and adult populations
Headquartered in San Diego, CA, Vical is independently pioneering the development of paradigm-changing DNA vaccines, and is partnering with such industry leaders as Astellas, AnGes, Bristol-Myers Squibb, Merck & Co., and Merial.